Assessment of the 4-factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study

Fortunato Morabito; Giovanni Tripepi; Giovanni Del Poeta; Francesca Romana Mauro; Gianluigi Reda; Paolo Sportoletti; Luca Laurenti; Marta Coscia; Yair Herishanu; Marzia Varettoni; Roberta Murru; Annalisa Chiarenza; Andrea Visentin; Adalgisa Condoluci; Riccardo Moia; Daniela Pietrasanta; Giacomo Loseto; Ugo Consoli; Ilaria Scortechini; Francesca Maria Rossi; Antonella Zucchetto; Ernesto Vigna; Enrica Antonia Martino; Francesco Mendicino; Cirino Botta; Daniele Caracciolo; Ramona Cassin; Graziella D'Arrigo; Sara Galimberti; Angela Rago; Ilaria Angeletti; Annalisa Biagi; Ilaria Del Giudice; Riccardo Bomben; Antonino Neri; Gilberto Fronza; Giovanna Cutrona; Davide Rossi; Francesco Di Raimondo; Antonio Cuneo; Gianluca Gaidano; Aaron Polliack; Livio Trentin; Robin Foà; Manlio Ferrarini; Valter Gattei; Massimo Gentile

doi:10.1002/ajh.26127

Assessment of the 4-factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study

Fortunato Morabito^*, Giovanni Tripepi, Giovanni Del Poeta, Francesca Romana Mauro, Gianluigi Reda, Paolo Sportoletti, Luca Laurenti, Marta Coscia, Yair Herishanu, Marzia Varettoni, Roberta Murru, Annalisa Chiarenza, Andrea Visentin, Adalgisa Condoluci, Riccardo Moia, Daniela Pietrasanta, Giacomo Loseto, Ugo Consoli, Ilaria Scortechini, Francesca Maria RossiAntonella Zucchetto, Ernesto Vigna, Enrica Antonia Martino, Francesco Mendicino, Cirino Botta, Daniele Caracciolo, Ramona Cassin, Graziella D'Arrigo, Sara Galimberti, Angela Rago, Ilaria Angeletti, Annalisa Biagi, Ilaria Del Giudice, Riccardo Bomben, Antonino Neri, Gilberto Fronza, Giovanna Cutrona, Davide Rossi, Francesco Di Raimondo, Antonio Cuneo, Gianluca Gaidano, Aaron Polliack, Livio Trentin, Robin Foà, Manlio Ferrarini, Valter Gattei, Massimo Gentile^*

^*Corresponding author for this work

Hematology

Research output: Contribution to journal › Letter › peer-review

12 Scopus citations

Original language	English
Pages (from-to)	E168-E171
Journal	American Journal of Hematology
Volume	96
Issue number	5
DOIs	https://doi.org/10.1002/ajh.26127
State	Published - 1 May 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/ajh.26127

Cite this

Morabito, F., Tripepi, G., Del Poeta, G., Mauro, F. R., Reda, G., Sportoletti, P., Laurenti, L., Coscia, M., Herishanu, Y., Varettoni, M., Murru, R., Chiarenza, A., Visentin, A., Condoluci, A., Moia, R., Pietrasanta, D., Loseto, G., Consoli, U., Scortechini, I., ... Gentile, M. (2021). Assessment of the 4-factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study. American Journal of Hematology, 96(5), E168-E171. https://doi.org/10.1002/ajh.26127

@article{df05c4eb7afb4e4ba00fe639dc1f2260,

title = "Assessment of the 4-factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study",

author = "Fortunato Morabito and Giovanni Tripepi and {Del Poeta}, Giovanni and Mauro, {Francesca Romana} and Gianluigi Reda and Paolo Sportoletti and Luca Laurenti and Marta Coscia and Yair Herishanu and Marzia Varettoni and Roberta Murru and Annalisa Chiarenza and Andrea Visentin and Adalgisa Condoluci and Riccardo Moia and Daniela Pietrasanta and Giacomo Loseto and Ugo Consoli and Ilaria Scortechini and Rossi, {Francesca Maria} and Antonella Zucchetto and Ernesto Vigna and Martino, {Enrica Antonia} and Francesco Mendicino and Cirino Botta and Daniele Caracciolo and Ramona Cassin and Graziella D'Arrigo and Sara Galimberti and Angela Rago and Ilaria Angeletti and Annalisa Biagi and {Del Giudice}, Ilaria and Riccardo Bomben and Antonino Neri and Gilberto Fronza and Giovanna Cutrona and Davide Rossi and {Di Raimondo}, Francesco and Antonio Cuneo and Gianluca Gaidano and Aaron Polliack and Livio Trentin and Robin Fo{\`a} and Manlio Ferrarini and Valter Gattei and Massimo Gentile",

note = "Funding Information: Associazione Italiana Ricerca sul Cancro (AIRC) Grant 5 x mille n.9980, (to F.M.); AIRC and Fondazione CaRiCal co‐financed Multi‐Unit Regional Grant 2014 n.16695 (to F.M.) Associazione Italiana Ricerca Cancro (AIRC), Investigator Grant IG‐21687 (to V.G.) and IG‐5506 (to G.F.); Progetto Ricerca Finalizzata PE‐2016‐02362756 (to V.G.), and RF‐2018‐12 365 790 (to A.Z.), Ministero della Salute, Rome, Italy; Compagnia S. Paolo, Turin, Italy (Project 2017.0526 to G.F.) and by the Ministry of Health (Project 5x1000, 2015 and 2016 and Current Research 2016 to G.F.). Funding of the project was provided by an unrestricted contribution from GILEAD Sciences Srl. The funding sources had no role in identifying statements, abstracting data, synthesizing results, grading evidence or preparing the manuscript, or in the decision to submit the manuscript for publication (ISR‐17‐10 250). ",

year = "2021",

month = may,

day = "1",

doi = "10.1002/ajh.26127",

language = "אנגלית",

volume = "96",

pages = "E168--E171",

journal = "American Journal of Hematology",

issn = "0361-8609",

publisher = "John Wiley and Sons Inc.",

number = "5",

}

Morabito, F, Tripepi, G, Del Poeta, G, Mauro, FR, Reda, G, Sportoletti, P, Laurenti, L, Coscia, M, Herishanu, Y, Varettoni, M, Murru, R, Chiarenza, A, Visentin, A, Condoluci, A, Moia, R, Pietrasanta, D, Loseto, G, Consoli, U, Scortechini, I, Rossi, FM, Zucchetto, A, Vigna, E, Martino, EA, Mendicino, F, Botta, C, Caracciolo, D, Cassin, R, D'Arrigo, G, Galimberti, S, Rago, A, Angeletti, I, Biagi, A, Del Giudice, I, Bomben, R, Neri, A, Fronza, G, Cutrona, G, Rossi, D, Di Raimondo, F, Cuneo, A, Gaidano, G, Polliack, A, Trentin, L, Foà, R, Ferrarini, M, Gattei, V & Gentile, M 2021, 'Assessment of the 4-factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study', American Journal of Hematology, vol. 96, no. 5, pp. E168-E171. https://doi.org/10.1002/ajh.26127

TY - JOUR

T1 - Assessment of the 4-factor score

T2 - Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study

AU - Morabito, Fortunato

AU - Tripepi, Giovanni

AU - Del Poeta, Giovanni

AU - Mauro, Francesca Romana

AU - Reda, Gianluigi

AU - Sportoletti, Paolo

AU - Laurenti, Luca

AU - Coscia, Marta

AU - Herishanu, Yair

AU - Varettoni, Marzia

AU - Murru, Roberta

AU - Chiarenza, Annalisa

AU - Visentin, Andrea

AU - Condoluci, Adalgisa

AU - Moia, Riccardo

AU - Pietrasanta, Daniela

AU - Loseto, Giacomo

AU - Consoli, Ugo

AU - Scortechini, Ilaria

AU - Rossi, Francesca Maria

AU - Zucchetto, Antonella

AU - Vigna, Ernesto

AU - Martino, Enrica Antonia

AU - Mendicino, Francesco

AU - Botta, Cirino

AU - Caracciolo, Daniele

AU - Cassin, Ramona

AU - D'Arrigo, Graziella

AU - Galimberti, Sara

AU - Rago, Angela

AU - Angeletti, Ilaria

AU - Biagi, Annalisa

AU - Del Giudice, Ilaria

AU - Bomben, Riccardo

AU - Neri, Antonino

AU - Fronza, Gilberto

AU - Cutrona, Giovanna

AU - Rossi, Davide

AU - Di Raimondo, Francesco

AU - Cuneo, Antonio

AU - Gaidano, Gianluca

AU - Polliack, Aaron

AU - Trentin, Livio

AU - Foà, Robin

AU - Ferrarini, Manlio

AU - Gattei, Valter

AU - Gentile, Massimo

N1 - Funding Information: Associazione Italiana Ricerca sul Cancro (AIRC) Grant 5 x mille n.9980, (to F.M.); AIRC and Fondazione CaRiCal co‐financed Multi‐Unit Regional Grant 2014 n.16695 (to F.M.) Associazione Italiana Ricerca Cancro (AIRC), Investigator Grant IG‐21687 (to V.G.) and IG‐5506 (to G.F.); Progetto Ricerca Finalizzata PE‐2016‐02362756 (to V.G.), and RF‐2018‐12 365 790 (to A.Z.), Ministero della Salute, Rome, Italy; Compagnia S. Paolo, Turin, Italy (Project 2017.0526 to G.F.) and by the Ministry of Health (Project 5x1000, 2015 and 2016 and Current Research 2016 to G.F.). Funding of the project was provided by an unrestricted contribution from GILEAD Sciences Srl. The funding sources had no role in identifying statements, abstracting data, synthesizing results, grading evidence or preparing the manuscript, or in the decision to submit the manuscript for publication (ISR‐17‐10 250).

PY - 2021/5/1

Y1 - 2021/5/1

UR - http://www.scopus.com/inward/record.url?scp=85101418459&partnerID=8YFLogxK

U2 - 10.1002/ajh.26127

DO - 10.1002/ajh.26127

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 33580969

AN - SCOPUS:85101418459

SN - 0361-8609

VL - 96

SP - E168-E171

JO - American Journal of Hematology

JF - American Journal of Hematology

IS - 5

ER -

Assessment of the 4-factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study

UN SDGs

Access to Document

Other files and links

Cite this